BIOCORP

is a French manufacturing company specializing in connected devices. Since October 2023, BIOCORP is a 100% Novo Nordisk company. The production plant is located in Issoire and the R&D and operational support teams' headquarters in Cournon d’Auvergne. The company, founded in 1997, focuses on developing innovative connected devices to manage various diseases. Their flagship product, Mallya, is a medical device dedicated to patients living with diabetes, turning any insulin pen into a smart device. With a team of 85 employees, BIOCORP is dedicated to offering professional innovative solutions to improve patients' daily lives. Despite its rapid growth, the company maintains its startup spirit, fostering an environment of agility and innovation. As investors seek opportunities in the healthcare technology sector, BIOCORP presents itself as a promising venture, offering limitless solutions for people's health.